Clinical spectrum of allergic and pseudoallergic drug reactions

Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on imm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 1984-10, Vol.74 (4), p.558-566
1. Verfasser: Mathews, Kenneth P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 566
container_issue 4
container_start_page 558
container_title Journal of allergy and clinical immunology
container_volume 74
creator Mathews, Kenneth P.
description Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.
doi_str_mv 10.1016/0091-6749(84)90107-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_14250631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0091674984901076</els_id><sourcerecordid>14250631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-32409c03311369b3df663bcda6a8acea6bc82e524534380279cead4aa1e789bb3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotVbfQGFWoovR3CaTbBQp3qDgRtchk5wpkbmZzAi-vaktXbo6t__8h_MhdE7wDcFE3GKsSC5Krq4kv1aY4DIXB2hOsEqJpMUhmu8lx-gkxk-caibVDM0ExZIyOkf3y8Z33pomiwPYMUxt1teZaRoIa28z07lsiDC5ft9yYVpnAYwdfd_FU3RUmybC2S4u0MfT4_vyJV-9Pb8uH1a5LTAec0Y5VhYzRggTqmKuFoJV1hlhpLFgRGUlhYLygnEmMS1VajpuDIFSqqpiC3S59R1C_zVBHHXro4WmMR30U9SE0wILRpKQb4U29DEGqPUQfGvCjyZYb7jpDRS9gaIl13_ctEhrFzv_qWrB7Zd2oNL8bjuH9OS3h6Cj9dBZcD4kbtr1_v8Dv5I-fDI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14250631</pqid></control><display><type>article</type><title>Clinical spectrum of allergic and pseudoallergic drug reactions</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mathews, Kenneth P.</creator><creatorcontrib>Mathews, Kenneth P.</creatorcontrib><description>Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/0091-6749(84)90107-6</identifier><identifier>PMID: 6208232</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Anaphylatoxins - pharmacology ; Anaphylaxis - immunology ; Angioedema - immunology ; Antibody-Dependent Cell Cytotoxicity ; Antigen-Antibody Complex - adverse effects ; Basophils - immunology ; Dermatitis, Contact - immunology ; Drug Hypersensitivity - classification ; Drug Hypersensitivity - immunology ; Erythema Nodosum - chemically induced ; Histamine Release - drug effects ; Humans ; Iatrogenic Disease ; Immunoglobulin E - immunology ; Ionophores - pharmacology ; Mast Cells - immunology ; Penicillins - adverse effects ; Respiratory Tract Diseases - immunology ; Urticaria - immunology</subject><ispartof>Journal of allergy and clinical immunology, 1984-10, Vol.74 (4), p.558-566</ispartof><rights>1984</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-32409c03311369b3df663bcda6a8acea6bc82e524534380279cead4aa1e789bb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0091674984901076$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6208232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mathews, Kenneth P.</creatorcontrib><title>Clinical spectrum of allergic and pseudoallergic drug reactions</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.</description><subject>Anaphylatoxins - pharmacology</subject><subject>Anaphylaxis - immunology</subject><subject>Angioedema - immunology</subject><subject>Antibody-Dependent Cell Cytotoxicity</subject><subject>Antigen-Antibody Complex - adverse effects</subject><subject>Basophils - immunology</subject><subject>Dermatitis, Contact - immunology</subject><subject>Drug Hypersensitivity - classification</subject><subject>Drug Hypersensitivity - immunology</subject><subject>Erythema Nodosum - chemically induced</subject><subject>Histamine Release - drug effects</subject><subject>Humans</subject><subject>Iatrogenic Disease</subject><subject>Immunoglobulin E - immunology</subject><subject>Ionophores - pharmacology</subject><subject>Mast Cells - immunology</subject><subject>Penicillins - adverse effects</subject><subject>Respiratory Tract Diseases - immunology</subject><subject>Urticaria - immunology</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotVbfQGFWoovR3CaTbBQp3qDgRtchk5wpkbmZzAi-vaktXbo6t__8h_MhdE7wDcFE3GKsSC5Krq4kv1aY4DIXB2hOsEqJpMUhmu8lx-gkxk-caibVDM0ExZIyOkf3y8Z33pomiwPYMUxt1teZaRoIa28z07lsiDC5ft9yYVpnAYwdfd_FU3RUmybC2S4u0MfT4_vyJV-9Pb8uH1a5LTAec0Y5VhYzRggTqmKuFoJV1hlhpLFgRGUlhYLygnEmMS1VajpuDIFSqqpiC3S59R1C_zVBHHXro4WmMR30U9SE0wILRpKQb4U29DEGqPUQfGvCjyZYb7jpDRS9gaIl13_ctEhrFzv_qWrB7Zd2oNL8bjuH9OS3h6Cj9dBZcD4kbtr1_v8Dv5I-fDI</recordid><startdate>198410</startdate><enddate>198410</enddate><creator>Mathews, Kenneth P.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>198410</creationdate><title>Clinical spectrum of allergic and pseudoallergic drug reactions</title><author>Mathews, Kenneth P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-32409c03311369b3df663bcda6a8acea6bc82e524534380279cead4aa1e789bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Anaphylatoxins - pharmacology</topic><topic>Anaphylaxis - immunology</topic><topic>Angioedema - immunology</topic><topic>Antibody-Dependent Cell Cytotoxicity</topic><topic>Antigen-Antibody Complex - adverse effects</topic><topic>Basophils - immunology</topic><topic>Dermatitis, Contact - immunology</topic><topic>Drug Hypersensitivity - classification</topic><topic>Drug Hypersensitivity - immunology</topic><topic>Erythema Nodosum - chemically induced</topic><topic>Histamine Release - drug effects</topic><topic>Humans</topic><topic>Iatrogenic Disease</topic><topic>Immunoglobulin E - immunology</topic><topic>Ionophores - pharmacology</topic><topic>Mast Cells - immunology</topic><topic>Penicillins - adverse effects</topic><topic>Respiratory Tract Diseases - immunology</topic><topic>Urticaria - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mathews, Kenneth P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mathews, Kenneth P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical spectrum of allergic and pseudoallergic drug reactions</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>1984-10</date><risdate>1984</risdate><volume>74</volume><issue>4</issue><spage>558</spage><epage>566</epage><pages>558-566</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>6208232</pmid><doi>10.1016/0091-6749(84)90107-6</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 1984-10, Vol.74 (4), p.558-566
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_14250631
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Anaphylatoxins - pharmacology
Anaphylaxis - immunology
Angioedema - immunology
Antibody-Dependent Cell Cytotoxicity
Antigen-Antibody Complex - adverse effects
Basophils - immunology
Dermatitis, Contact - immunology
Drug Hypersensitivity - classification
Drug Hypersensitivity - immunology
Erythema Nodosum - chemically induced
Histamine Release - drug effects
Humans
Iatrogenic Disease
Immunoglobulin E - immunology
Ionophores - pharmacology
Mast Cells - immunology
Penicillins - adverse effects
Respiratory Tract Diseases - immunology
Urticaria - immunology
title Clinical spectrum of allergic and pseudoallergic drug reactions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T05%3A16%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20spectrum%20of%20allergic%20and%20pseudoallergic%20drug%20reactions&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Mathews,%20Kenneth%20P.&rft.date=1984-10&rft.volume=74&rft.issue=4&rft.spage=558&rft.epage=566&rft.pages=558-566&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/0091-6749(84)90107-6&rft_dat=%3Cproquest_cross%3E14250631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14250631&rft_id=info:pmid/6208232&rft_els_id=0091674984901076&rfr_iscdi=true